Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $972.05 | 50 | 96.4% |
| Consulting Fee | $26.28 | 1 | 2.6% |
| Education | $10.52 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $161.90 | 9 | $0 (2023) |
| Amgen Inc. | $125.54 | 9 | $0 (2023) |
| Theravance Biopharma, Inc. | $123.87 | 1 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $79.95 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $75.57 | 5 | $0 (2018) |
| Astellas Pharma US Inc | $54.75 | 3 | $0 (2018) |
| Alkermes, Inc. | $47.20 | 2 | $0 (2019) |
| Exact Sciences Corporation | $46.85 | 2 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $40.11 | 3 | $0 (2021) |
| ABBVIE INC. | $35.80 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $167.53 | 8 | PFIZER INC. ($67.37) |
| 2022 | $52.24 | 4 | Amgen Inc. ($35.21) |
| 2021 | $176.36 | 11 | PFIZER INC. ($33.14) |
| 2020 | $119.57 | 8 | PFIZER INC. ($47.88) |
| 2019 | $56.97 | 3 | Alkermes, Inc. ($23.80) |
| 2018 | $280.30 | 9 | Theravance Biopharma, Inc. ($123.87) |
| 2017 | $155.88 | 9 | AstraZeneca Pharmaceuticals LP ($60.52) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: WOMENS HEALTH | ||||||
| 10/18/2023 | PFIZER INC. | PREMARIN (Drug), ESTRING, MYFEMBREE | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: WOMENS HEALTH | ||||||
| 09/27/2023 | Athena Bioscience, LLC | QDOLO (Drug) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Oncology | ||||||
| 03/01/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardiology | ||||||
| 01/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Oncology | ||||||
| 11/02/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Inflammation | ||||||
| 07/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 06/02/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Inflammation | ||||||
| 03/10/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Inflammation | ||||||
| 10/12/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: VACCINES | ||||||
| 09/16/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Cardiovascular | ||||||
| 08/11/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Inflammation | ||||||
| 05/27/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: Cardiovascular | ||||||
| 04/29/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Inflammation | ||||||
| 04/28/2021 | Clarus Therapeutics Inc. | JATENZO (Drug), JATENZO, JATENZO | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Testosterone Replacement Therapy | ||||||
| 04/08/2021 | Qiagen, LLC | — | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| 04/01/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2020 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Neuroscience | ||||||
| 11/11/2020 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 956 | 1,513 | $119,290 | $65,734 |
| 2022 | 19 | 623 | 1,164 | $94,035 | $53,763 |
| 2021 | 24 | 1,146 | 1,588 | $140,005 | $91,569 |
| 2020 | 21 | 1,082 | 1,489 | $139,610 | $77,414 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 125 | 371 | $48,230 | $30,962 | 64.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $16,150 | $9,764 | 60.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 90 | 90 | $12,150 | $6,734 | 55.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 71 | $6,745 | $4,119 | 61.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $3,000 | $2,352 | 78.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 93 | 93 | $4,610 | $2,262 | 49.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 96 | 96 | $2,880 | $1,618 | 56.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 85 | 85 | $2,550 | $1,432 | 56.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 46 | 46 | $2,530 | $1,328 | 52.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 108 | $5,940 | $1,076 | 18.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 46 | 46 | $2,290 | $1,007 | 44.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 41 | 41 | $2,050 | $992.20 | 48.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 22 | $1,870 | $810.47 | 43.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 18 | 18 | $990.00 | $623.16 | 62.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 67 | 98 | $2,450 | $213.40 | 8.7% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 11 | $275.00 | $153.01 | 55.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 11 | 23 | $690.00 | $137.99 | 20.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 22 | 101 | $1,010 | $116.63 | 11.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 21 | 96 | $2,880 | $34.68 | 1.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 371 | $48,205 | $32,466 | 67.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 94 | $8,870 | $5,889 | 66.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $6,270 | $4,139 | 66.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 35 | 36 | $4,860 | $2,838 | 58.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 25 | 40 | $3,400 | $1,610 | 47.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 48 | $2,640 | $1,304 | 49.4% |
About Dr. Robert Madden, MD
Dr. Robert Madden, MD is a Internal Medicine healthcare provider based in Rome, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023224151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Madden, MD has received a total of $1,009 in payments from pharmaceutical and medical device companies, with $167.53 received in 2023. These payments were reported across 52 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($972.05).
As a Medicare-enrolled provider, Madden has provided services to 3,807 Medicare beneficiaries, totaling 5,754 services with total Medicare billing of $288,480. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Rome, GA
- Active Since 05/15/2007
- Last Updated 10/19/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023224151
Products in Payments
- VIBATIV (Drug) $123.87
- OCALIVA (Drug) $79.95
- FARXIGA (Drug) $75.57
- Otezla (Drug) $66.80
- PREMARIN (Drug) $49.11
- CHANTIX (Drug) $47.88
- Cologuard Collection Kit (Device) $46.85
- Aimovig (Biological) $42.53
- Myrbetriq (Drug) $40.75
- BELSOMRA (Drug) $40.11
- VRAYLAR (Drug) $35.80
- Livalo (Drug) $30.40
- ELIQUIS (Drug) $29.68
- ENTRESTO (Drug) $26.47
- ARISTADA (Drug) $23.80
- Aristada 441 mg (Drug) $23.40
- JATENZO (Drug) $21.76
- PREVNAR 13 (Biological) $21.72
- Vascepa (Drug) $20.58
- QDOLO (Drug) $18.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rome
Dr. Kunal Patel, M.d, M.D
Internal Medicine — Payments: $15,383
Raul Gonzalez, Md, MD
Internal Medicine — Payments: $12,656
Mourad Nessim, Md, MD
Internal Medicine — Payments: $10,097
Dr. Joseph Herren, Md, MD
Internal Medicine — Payments: $8,646
George Hotz, M.d, M.D
Internal Medicine — Payments: $6,225
Anandita Arora, Md, MD
Internal Medicine — Payments: $5,451